144 related articles for article (PubMed ID: 10807671)
1. Protective effects of cyclosporin-A in splanchnic artery occlusion shock.
Squadrito F; Altavilla D; Squadrito G; Ferlito M; Deodato B; Arlotta M; Minutoli L; Campo GM; Bova A; Quartarone C; Urna G; Sardella A; Saitta A; Caputi AP
Br J Pharmacol; 2000 May; 130(2):339-44. PubMed ID: 10807671
[TBL] [Abstract][Full Text] [Related]
2. Adrenocorticotropin reverses vascular dysfunction and protects against splanchnic artery occlusion shock.
Squadrito F; Guarini S; Altavilla D; Squadrito G; Campo GM; Arlotta M; Quartarone C; Saitta A; Cucinotta D; Bazzani C; Cainazzo MM; Mioni C; Bertolini A; Caputi AP
Br J Pharmacol; 1999 Oct; 128(3):816-22. PubMed ID: 10516667
[TBL] [Abstract][Full Text] [Related]
3. Recombinant human erythropoietin inhibits iNOS activity and reverts vascular dysfunction in splanchnic artery occlusion shock.
Squadrito F; Altavilla D; Squadrito G; Campo GM; Arlotta M; Quartarone C; Saitta A; Caputi AP
Br J Pharmacol; 1999 May; 127(2):482-8. PubMed ID: 10385249
[TBL] [Abstract][Full Text] [Related]
4. Participation of tumour necrosis factor and nitric oxide in the mediation of vascular dysfunction in splanchnic artery occlusion shock.
Squadrito F; Altavilla D; Canale P; Ioculano M; Campo GM; Ammendolia L; Ferlito M; Zingarelli B; Squadrito G; Saitta A
Br J Pharmacol; 1994 Dec; 113(4):1153-8. PubMed ID: 7889268
[TBL] [Abstract][Full Text] [Related]
5. Effects of S-ethylisothiourea, a potent inhibitor of nitric oxide synthase, alone or in combination with a nitric oxide donor in splanchnic artery occlusion shock.
Squadrito F; Altavilla D; Squadrito G; Campo GM; Ioculano M; Canale P; Rossi F; Saitta A; Caputi AP
Br J Pharmacol; 1996 Sep; 119(1):23-8. PubMed ID: 8872352
[TBL] [Abstract][Full Text] [Related]
6. Tacrolimus suppresses tumour necrosis factor-alpha and protects against splanchnic artery occlusion shock.
Squadrito F; Altavilla D; Squadrito G; Ferlito M; Campo GM; Arlotta M; Grimaldi S; Quartarone C; Saitta A; Caputi AP
Br J Pharmacol; 1999 May; 127(2):498-504. PubMed ID: 10385251
[TBL] [Abstract][Full Text] [Related]
7. The involvement of tumour necrosis factor-alpha in the protective effects of 17 beta oestradiol in splanchnic ischaemia-reperfusion injury.
Squadrito F; Altavilla D; Squadrito G; Campo GM; Arlotta M; Arcoraci V; Minutoli L; Saitta A; Caputi AP
Br J Pharmacol; 1997 Aug; 121(8):1782-8. PubMed ID: 9283718
[TBL] [Abstract][Full Text] [Related]
8. Beneficial effects of 3-aminobenzamide, an inhibitor of poly (ADP-ribose) synthetase in a rat model of splanchnic artery occlusion and reperfusion.
Cuzzocrea S; Zingarelli B; Costantino G; Szabó A; Salzman AL; Caputi AP; Szabó C
Br J Pharmacol; 1997 Jul; 121(6):1065-74. PubMed ID: 9249240
[TBL] [Abstract][Full Text] [Related]
9. Sulfatide reduces leucocyte accumulation and reverts vascular failure in splanchnic artery occlusion shock.
Squadrito F; Altavilla D; Squadrito G; Campo GM; Arlotta M; Quartarone C; Minutoli L; Ferlito M; Saitta A; Caputi AP
Eur J Pharmacol; 1998 Nov; 361(1):101-8. PubMed ID: 9851547
[TBL] [Abstract][Full Text] [Related]
10. Passive immunization with antibodies against tumor necrosis factor (TNF-alpha) protects from the lethality of splanchnic artery occlusion shock.
Squadrito F; Altavilla D; Ioculano M; Calapai G; Zingarelli B; Saitta A; Campo GM; Rizzo A; Caputi AP
Circ Shock; 1992 Jul; 37(3):236-44. PubMed ID: 1423915
[TBL] [Abstract][Full Text] [Related]
11. The effects of recombinant human granulocyte-colony stimulating factor on vascular dysfunction and splanchnic ischaemia-reperfusion injury.
Squadrito F; Altavilla D; Squadrito G; Campo GM; Ioculano M; Ammedolia L; Arlotta M; Saitta A; Caputi AP
Br J Pharmacol; 1997 Jan; 120(2):333-9. PubMed ID: 9117128
[TBL] [Abstract][Full Text] [Related]
12. Role of constitutive nitric oxide synthase and peroxynitrite production in a rat model of splanchnic artery occlusion shock.
Cuzzocrea S; Zingarelli B; Caputi AP
Life Sci; 1998; 63(9):789-99. PubMed ID: 9740316
[TBL] [Abstract][Full Text] [Related]
13. Protective effects of a new stable, highly active SOD mimetic, M40401 in splanchnic artery occlusion and reperfusion.
Cuzzocrea S; Mazzon E; Dugo L; Caputi AP; Aston K; Riley DP; Salvemini D
Br J Pharmacol; 2001 Jan; 132(1):19-29. PubMed ID: 11156557
[TBL] [Abstract][Full Text] [Related]
14. The lazaroid, U-74389G, inhibits inducible nitric oxide synthase activity, reverses vascular failure and protects against endotoxin shock.
Altavilla D; Squadrito F; Campo GM; Squadrito G; Arlotta M; Urna G; Sardella A; Quartarone C; Saitta A; Caputi AP
Eur J Pharmacol; 1999 Mar; 369(1):49-55. PubMed ID: 10204681
[TBL] [Abstract][Full Text] [Related]
15. Activation of the cholinergic anti-inflammatory pathway reduces NF-kappab activation, blunts TNF-alpha production, and protects againts splanchic artery occlusion shock.
Altavilla D; Guarini S; Bitto A; Mioni C; Giuliani D; Bigiani A; Squadrito G; Minutoli L; Venuti FS; Messineo F; De Meo V; Bazzani C; Squadrito F
Shock; 2006 May; 25(5):500-6. PubMed ID: 16680015
[TBL] [Abstract][Full Text] [Related]
16. Role of nitric oxide in hemorrhagic shock-induced bacterial translocation.
Hua TC; Moochhala SM
J Surg Res; 2000 Oct; 93(2):247-56. PubMed ID: 11027467
[TBL] [Abstract][Full Text] [Related]
17. Splanchnic artery occlusion shock: vinblastine-induced leukopenia reduces tumour necrosis factor and thromboxane A2 formation, and increases survival rate.
Canale P; Squadrito F; Zingarelli B; Altavilla D; Ioculano M; Campo GM; Caputi AP
Pharmacol Res; 1993; 27(1):61-71. PubMed ID: 8456059
[TBL] [Abstract][Full Text] [Related]
18. Splanchnic artery occlusion shock in the rat: effects of the calcium entry blockers nimodipine and verapamil.
Sturniolo R; Altavilla D; Berlinghieri MC; Squadrito F; Caputi AP
Circ Shock; 1988; 24(1):43-53. PubMed ID: 3345594
[TBL] [Abstract][Full Text] [Related]
19. Discrepant effects of inducible nitric oxide synthase modulation on systemic and splanchnic endothelial nitric oxide synthase activity and expression in cirrhotic rats.
Malyshev E; Tazi KA; Moreau R; Lebrec D
J Gastroenterol Hepatol; 2007 Dec; 22(12):2195-201. PubMed ID: 18031380
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of tumour necrosis factor and reversal of endotoxin-induced shock by U-83836E, a 'second generation' lazaroid in rats.
Altavilla D; Squadrito F; Serrano M; Campo GM; Squadrito G; Arlotta M; Urna G; Sardella A; Saitta A; Caputi AP
Br J Pharmacol; 1998 Jul; 124(6):1293-9. PubMed ID: 9720803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
